Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma.

Maria Chiara TisiRossella PaoliniFrancesco PiazzaErika RavelliCristina TecchioRoberto SartoriBarbara FamengoEmanuele Stefano Giovanni D'AmoreGiuseppe CarliOmar PerbelliniEros Di BonaMarco RuggeriCarlo Visco

Published in: American journal of hematology (2018)

Keyphrases

diffuse large b cell lymphoma
acute myeloid leukemia
high dose
chronic lymphocytic leukemia
hodgkin lymphoma
acute lymphoblastic leukemia
low dose
multiple myeloma